Clinical Trials Listing, filtered by condition | Lehigh Valley Health Network

What type of appointment are you looking for?

Appointment with

Clinical Trials

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 10 of 131 Clinical Trials

Clinical Research Trial

Prevail Global

A randomized controlled study of the Prevail Drug-Coated Balloon in subjects with in-stent restenosis and a single arm prospectively enrolled study of the Prevail Drug-Coated Balloon for de novo lesions

Doctor(s) Running This Study

Shailendra Singh, MD

Clinical Research Trial

Dal-GenE-2

A phase III, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in a genetically defined population with recent Acute Coronary Syndrome (ACS): The DAL-302

Doctor(s) Running This Study

Eric E. Elgin, MD

Clinical Research Trial

RESTORE

RESTORE Study (REdo tranScatheter aortic valve replacement for Transcatheter aOrtic valve failuRE)

Doctor(s) Running This Study

Dzanan Ramic, MD

Clinical Research Trial

RESTORE

RESTORE Study (REdo tranScatheter aortic valve replacement for Transcatheter aOrtic valve failuRE)

Doctor(s) Running This Study

Dzanan Ramic, MD

Clinical Research Trial

ENABLE

REal world experieNce with BRIUMVI® (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study (ENABLE)

Doctor(s) Running This Study

Gary W. Clauser, MD

Clinical Research Trial

C – Beyond AT-01B-007

Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed-dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination (SOF/VEL FDC) in Subjects with Chronic Hepatitis C

Doctor(s) Running This Study

Orlando J. Penaloza, MD

Clinical Research Trial

NRG-GY037 Cervical Cancer

A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

Doctor(s) Running This Study

Maged F. Khalil, MD

Clinical Research Trial